Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?
Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.
North General, MSK, Form Cancer Prevention Center.
Human Genome Consortium Completes “Working Draft”.
NCI Plans $40M In Grants For Cancer Outcomes Studies.
Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.
FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.
Sustained-Release Leuprolide Under Study In Phase III Trial.
Celgene Signs CRADA With NCI For Development Of CDC-501.
Trending Stories
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pam Bondi diagnosed with thyroid cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center









